Filing Details
- Accession Number:
- 0001140361-15-018532
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-05-08 16:25:10
- Reporting Period:
- 2015-05-08
- Filing Date:
- 2015-05-08
- Accepted Time:
- 2015-05-08 16:25:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1262823 | Westlake Chemical Corp | WLK | Industrial Organic Chemicals (2860) | 760346924 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1439749 | Andrew Kenner | 2801 Post Oak Boulevard, Suite 600 Houston TX 77056 | Vp - Manufacturing | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-05-06 | 6,092 | $30.05 | 18,273 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-05-06 | 2,526 | $22.92 | 20,799 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-05-06 | 8,618 | $72.27 | 12,181 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-05-06 | 2,161 | $72.32 | 10,020 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Option (right to buy) | Disposition | 2015-05-06 | 6,092 | $0.00 | 6,092 | $30.05 |
| Common Stock | Employee Option (right to buy) | Disposition | 2015-05-06 | 2,526 | $0.00 | 2,526 | $22.92 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2022-02-17 | No | 4 | M | Direct | |
| 0 | 2021-02-18 | No | 4 | M | Direct |
Footnotes
- In accordance with the Securities and Exchange Commission's No Action Letter dated June 25, 2008, we have aggregated the sales that occurred on May 6, 2015 for ease of reporting. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $72.25 to $72.34, inclusive. The reporting person undertakes to provide to Westlake Chemical Corp., any security holder of Westlake Chemical Corp. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
- In accordance with the Securities and Exchange Commission's No Action Letter dated June 25, 2008, we have aggregated the sales that occurred on May 6, 2015 for ease of reporting. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $72.31 to $72.34, inclusive. The reporting person undertakes to provide to Westlake Chemical Corp., any security holder of Westlake Chemical Corp. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
- The stock options are exercisable in three installments of 33%, 33% and 34% on February 17, 2013, 2014 and 2015, respectively.
- The stock options are exercisable in three installments of 33%, 33% and 34% on February 18, 2012, 2013 and 2014, respectively.
Billionaire Hedge Funds
